208 related articles for article (PubMed ID: 33289924)
1. White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health study.
Frey BM; Petersen M; Schlemm E; Mayer C; Hanning U; Engelke K; Fiehler J; Borof K; Jagodzinski A; Gerloff C; Thomalla G; Cheng B
Hum Brain Mapp; 2021 Apr; 42(5):1406-1415. PubMed ID: 33289924
[TBL] [Abstract][Full Text] [Related]
2. White matter integrity in small vessel disease is related to cognition.
Tuladhar AM; van Norden AG; de Laat KF; Zwiers MP; van Dijk EJ; Norris DG; de Leeuw FE
Neuroimage Clin; 2015; 7():518-24. PubMed ID: 25737960
[TBL] [Abstract][Full Text] [Related]
3. Network Localisation of White Matter Damage in Cerebral Small Vessel Disease.
Petersen M; Frey BM; Schlemm E; Mayer C; Hanning U; Engelke K; Fiehler J; Borof K; Jagodzinski A; Gerloff C; Thomalla G; Cheng B
Sci Rep; 2020 Jun; 10(1):9210. PubMed ID: 32514044
[TBL] [Abstract][Full Text] [Related]
4. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
[TBL] [Abstract][Full Text] [Related]
5. Equalization of Brain State Occupancy Accompanies Cognitive Impairment in Cerebral Small Vessel Disease.
Schlemm E; Frey BM; Mayer C; Petersen M; Fiehler J; Hanning U; Kühn S; Twerenbold R; Gallinat J; Gerloff C; Thomalla G; Cheng B
Biol Psychiatry; 2022 Oct; 92(7):592-602. PubMed ID: 35691727
[TBL] [Abstract][Full Text] [Related]
6. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
[TBL] [Abstract][Full Text] [Related]
7. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
8. Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936.
Ballerini L; Booth T; Valdés Hernández MDC; Wiseman S; Lovreglio R; Muñoz Maniega S; Morris Z; Pattie A; Corley J; Gow A; Bastin ME; Deary IJ; Wardlaw J
Neuroimage Clin; 2020; 25():102120. PubMed ID: 31887717
[TBL] [Abstract][Full Text] [Related]
9. Structural network changes in cerebral small vessel disease.
Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
[TBL] [Abstract][Full Text] [Related]
10. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
[TBL] [Abstract][Full Text] [Related]
11. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
12. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
[TBL] [Abstract][Full Text] [Related]
13. Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease.
Kang P; Ying C; Chen Y; Ford AL; An H; Lee JM
Stroke; 2022 May; 53(5):1570-1579. PubMed ID: 34886686
[TBL] [Abstract][Full Text] [Related]
14. Painting by lesions: White matter hyperintensities disrupt functional networks and global cognition.
Crockett RA; Hsu CL; Dao E; Tam R; Eng JJ; Handy TC; Liu-Ambrose T
Neuroimage; 2021 Aug; 236():118089. PubMed ID: 33882347
[TBL] [Abstract][Full Text] [Related]
15. Free-water diffusion MRI detects structural alterations surrounding white matter hyperintensities in the early stage of cerebral small vessel disease.
Mayer C; Nägele FL; Petersen M; Frey BM; Hanning U; Pasternak O; Petersen E; Gerloff C; Thomalla G; Cheng B
J Cereb Blood Flow Metab; 2022 Sep; 42(9):1707-1718. PubMed ID: 35410517
[TBL] [Abstract][Full Text] [Related]
16. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
Baykara E; Gesierich B; Adam R; Tuladhar AM; Biesbroek JM; Koek HL; Ropele S; Jouvent E; ; Chabriat H; Ertl-Wagner B; Ewers M; Schmidt R; de Leeuw FE; Biessels GJ; Dichgans M; Duering M
Ann Neurol; 2016 Oct; 80(4):581-92. PubMed ID: 27518166
[TBL] [Abstract][Full Text] [Related]
17. White matter hyperintensities at critical crossroads for executive function and verbal abilities in small vessel disease.
Camerino I; Sierpowska J; Reid A; Meyer NH; Tuladhar AM; Kessels RPC; de Leeuw FE; Piai V
Hum Brain Mapp; 2021 Mar; 42(4):993-1002. PubMed ID: 33231360
[TBL] [Abstract][Full Text] [Related]
18. White matter asymmetries in patients with cerebral small vessel disease.
Zhou H; Tang Y; Yuan Z
J Integr Neurosci; 2018; 17(2):159-167. PubMed ID: 29526848
[TBL] [Abstract][Full Text] [Related]
19. Changes of white matter integrity and structural network connectivity in nondemented cerebral small-vessel disease.
Liu C; Zou L; Tang X; Zhu W; Zhang G; Qin Y; Zhu W
J Magn Reson Imaging; 2020 Apr; 51(4):1162-1169. PubMed ID: 31448477
[TBL] [Abstract][Full Text] [Related]
20. Diffusion MRI harmonization enables joint-analysis of multicentre data of patients with cerebral small vessel disease.
de Brito Robalo BM; Biessels GJ; Chen C; Dewenter A; Duering M; Hilal S; Koek HL; Kopczak A; Yin Ka Lam B; Leemans A; Mok V; Onkenhout LP; van den Brink H; de Luca A
Neuroimage Clin; 2021; 32():102886. PubMed ID: 34911192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
